Excisional Biopsy as the Preferred Initial Diagnostic Strategy for Suspected Lymphoma

Guideline Recommendations (NCCN & ESMO)

First‑Line Biopsy Choice

When Excisional Biopsy Is Not Feasible – Core Needle Biopsy (CNB)

Limitations of Core Needle Biopsy

Limitations of Fine‑Needle Aspiration (FNA)

Impact on Treatment Decisions

All bullet points are derived from cited evidence in the Annals of Oncology (references @1‑@4) and reflect the current NCCN and ESMO guideline positions.

Lymphoma Diagnosis Guidelines

Primary Recommendation

• The National Comprehensive Cancer Network (NCCN) recommends an excisional or incisional biopsy as the standard for initial lymphoma diagnosis, as it provides both tissue architecture and immunophenotyping, which FNAC alone cannot reliably provide 5, 6, 7, 8, 9
• The NCCN explicitly states that FNAC alone is not suitable for making an initial diagnosis of non-Hodgkin lymphoma (NHL) 5, 6, 7
• For Hodgkin lymphoma, excisional biopsy is recommended, though core needle biopsy may be adequate if diagnostic; FNAC is insufficient except in unusual circumstances when combined with immunohistochemistry and judged adequate by an expert hematopathologist 10, 11

When FNAC May Be Acceptable (Limited Circumstances)

• FNAC can be considered sufficient for documenting relapse in patients with previously diagnosed lymphoma 5, 6, 7
• When lymph nodes are not easily accessible, a combination of core needle biopsy and FNAC together with ancillary techniques may suffice for diagnosis 5, 6, 7
• This exception applies particularly to chronic lymphocytic leukemia (CLL), where the combination approach is more acceptable 5, 6, 7

Why Excisional Biopsy is Superior

• Excisional/incisional biopsy preserves lymph node architecture, essential for accurate classification under the REAL/WHO system 5, 6, 7
• Excisional biopsy provides adequate tissue for comprehensive immunophenotyping, cytogenetics, FISH, and molecular studies required for specific lymphoma subtype diagnosis 5, 6, 7

Critical Pitfalls to Avoid

• Never rely on FNAC alone for initial diagnosis, as this violates established guidelines and risks misclassification 5, 6, 7
• Inadequate tissue sampling prevents histologic grading, which cannot be performed on FNAC specimens 12

Practical Algorithm for Biopsy Selection

• First-line: Excisional or incisional biopsy for all accessible lymph nodes in suspected new lymphoma diagnosis 5, 6, 7, 8, 9
• If node is inaccessible or patient cannot tolerate surgery: Core needle biopsy PLUS FNAC with comprehensive ancillary studies (immunohistochemistry, flow cytometry, PCR, FISH) 5, 6, 7
• If documenting known relapse: FNAC may be sufficient 5, 6, 7